BROADCASTS.com

b'

Abbvie ABBV Stock continues to remain a favorite of dividend investors because of it\'s high dividend yield as well as chances for some amazing capital appreciation. In today\'s video I go over Abbvie Pharmaceutical\'s business model and if their products will be in demand even after their patents expire. Abbvie\'s strong cash flow from its diversified product line continue to be able to fund it\'s high dividend yield. Abbvie has an impressive 5 year dividend growth rate of nearly 17% and has seen its share price rise considerably in the past 5 years. I also talk about some of their next in line products that will provide cash flow for the foreseeable future. Follow me on YouTube: CitizenoftheYear! Catch me where ever you get your podcast! Collect Cash Podcast!  Disclaimer:This is not financial advice and I am not a licensed financial advisor. Always do your own research before investing and work with a licensed financial advisor. These are my opinions for informational purposes only and not to be taken as investing advice.